Apitaf Life Science Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.22 M
- Company Age 13 Year, 24 Days
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 3.00 M
- Revenue Growth 6.20%
- Profit Growth 38.72%
- Ebitda 51.56%
- Net Worth 0.75%
- Total Assets -31.33%
About Apitaf Life Science
Apitaf Life Science Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 January 2012 and has a history of 13 years. Its registered office is in Shahjahanpur, Uttar Pradesh, India.
The Corporate was formerly known as Amicure Pharmaceuticals Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.22 M.
The company currently has active open charges totaling ₹3.00 M.
Abhijat Mishra and Ruchi Mishra serve as directors at the Company.
Company Details
- Location
Shahjahanpur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51101UP2012PTC048610
- Company No.
048610
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2012
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Apitaf Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijat Mishra  | Additional Director | 27-Feb-2019 | Current |
| Ruchi Mishra | Additional Director | 27-Feb-2019 | Current |
Financial Performance of Apitaf Life Science.
Apitaf Life Science Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 6.2% increase. The company also saw a substantial improvement in profitability, with a 38.72% increase in profit. The company's net worth moved up by a moderate rise of 0.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apitaf Life Science?
In 2017, Apitaf Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Royal Opulent Private LimitedAbhijat Mishra is a mutual person
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2014 | Indian Bank | ₹1.50 M | Open |
| 21 Jan 2013 | Indian Bank | ₹1.50 M | Open |
How Many Employees Work at Apitaf Life Science?
Unlock and access historical data on people associated with Apitaf Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apitaf Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apitaf Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
